Professional Documents
Culture Documents
D
A Research and Development
B Creation for the experimental medicine
C Clinical trials
D Human trials (mild COVID-19 patient symptoms) A B C E G H
E Human trials (moderate COVID-19 patient symptoms)
F Human trials (severe COVID-19 patient symptoms)
G Application to Food and Drugs Agency F
H General acceptability of manufactured medicine
Immediate
Description/Event Activity EF (Optimistic Finish LF (Pessimistic Finish) Slack Time
Predecessor
TIME = MONTHS
LEGEND
Event
Activity
Critical Path
Dummy activities
Critical Path
NO
NO
NO
NO
NO
YES
NO
NO